NIMH-1

DEPARTMENT OF HEALTH AND HUMAN SERVICES

NATIONAL INSTITUTES OF HEALTH

National Institute of Mental Health (NIMH)

FY 2021 Budget Page No.

Organization Chart...........................................................................................................................2

Appropriation Language ..................................................................................................................3

Amounts Available for Obligation...................................................................................................4

Budget Mechanism Table ................................................................................................................5

Major Changes in Budget Request ..................................................................................................6

Summary of Changes.......................................................................................................................7

Budget Graphs .................................................................................................................................8

Budget Authority by Activity ..........................................................................................................9

Authorizing Legislation .................................................................................................................10

Appropriations History ..................................................................................................................11

Justification of Budget Request .....................................................................................................12

Budget Authority by Object Class.................................................................................................23

Salaries and Expenses....................................................................................................................24

Detail of Full-Time Equivalent Employment (FTE) .....................................................................25

Detail of Positions..........................................................................................................................26
NIMH-2

National 

Advisory

Mental Health

Council

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health

 

Division of Services and

Intervention Research

Director

Robert Heinssen, Jr., Ph.D.

Division of Neuroscience 

and Basic Behavioral 

Science

Director

Linda S. Brady, Ph.D.

Division of AIDS

Research 

Director

Dianne M. Rausch, Ph.D.

Division of 

Translational

Research

Director

Sarah H. Lisanby, M.D.

Office of the Director

Director

Joshua A. Gordon, M.D., Ph.D.

Division of Extramural 

Activities

Director

Jean Noronha, Ph.D.

Division of Intramural

Research Programs

Director

Susan G. Amara, Ph.D. 
NIMH-3

NATIONAL INSTITUTES OF HEALTH

National Institute of Mental Health

For carrying out section 301 and title IV of the PHS Act with respect to mental health, 

[$1,968,374,000]$1,794,865,000.

NIH INNOVATION ACCOUNT, CURES ACT

(INCLUDING TRANSFER OF FUNDS)

For necessary expenses to carry out the purposes described in section 1001(b)(4) of the 21st 

Century Cures Act, in addition to amounts available for such purposes in the appropriations 

provided to the NIH in this Act, [$492,000,000]$404,000,000, to remain available until 

expended: Provided, That such amounts are appropriated pursuant to section 1001(b)(3) of such 

Act, are to be derived from amounts transferred under section 1001(b)(2)(A) of such Act, and 

may be transferred by the Director of the National Institutes of Health to other accounts of the

National Institutes of Health solely for the purposes provided in such Act: Provided further, That 

upon a determination by the Director that funds transferred pursuant to the previous proviso are 

not necessary for the purposes provided, such amounts may be transferred back to the Account: 

Provided further, That the transfer authority provided under this heading is in addition to any 

other transfer authority provided by law.
NIMH-4

Source of Funding FY 2019 Final FY 2020 Enacted FY 2021 President's 

Budget

Appropriation2 $1,870,296 $2,038,374 $1,844,865

Mandatory Appropriation: (non-add)

Type 1 Diabetes (0) (0) (0)

Other Mandatory financing (0) (0) (0)

Rescission 0 0 0

Sequestration 0 0 0

Secretary's Transfer -5,001 0 0

Subtotal, adjusted appropriation $1,865,295 $2,038,374 $1,844,865

OAR HIV/AIDS Transfers 6,390 4,592 0

HEAL Transfer from NINDS 0 0 0

Subtotal, adjusted budget authority $1,871,685 $2,042,966 $1,844,865

Unobligated balance, start of year3 0 2,022 0

Unobligated balance, end of year3

-2,022 0 0

Subtotal, adjusted budget authority $1,869,663 $2,044,988 $1,844,865

Unobligated balance lapsing -10 0 0

Total obligations $1,869,653 $2,044,988 $1,844,865

NATIONAL INSTITUTES OF HEALTH

National Institute of Mental Health

Amounts Available for Obligation1

(Dollars in Thousands)

1 Excludes the following amounts (in thousands) for reimbursable activities carried out by this account:

 FY 2019 - $5,439 FY 2020 - $10,050 FY 2021 - $10,050 

2

 Of which $57.5 million in FY 2019, $70.0 million in FY 2020, and $50.0 million in FY 2021 is derived by transfer from the NIH Innovation 

Account under the 21st Century Cures Act.

3

 Reflects 21st Century Cures Act funding not obligated in FY 2019, and carried over into FY 2020.
NIMH-5

No. Amount No. Amount No. Amount No. Amount

1,504 $815,909 1,643 $904,108 1,683 $921,029 40 $16,921

(127) 17,686 (118) 16,389 (107) 14,889 (-11) -1,500

49 29,371 54 32,177 34 20,078 -20 -12,100

603 377,304 666 416,042 449 262,227 -217 -153,814

1 213 1 233 1 146 0 -88

653 $406,888 721 $448,453 484 $282,451 -237 -$166,002

2,157 $1,240,483 2,364 $1,368,950 2,167 $1,218,368 -197 -$150,581

96 57,338 109 64,358 95 56,288 -14 -8,070

2,253 $1,297,821 2,473 $1,433,308 2,262 $1,274,656 -211 -$158,652

27 $67,412 38 $69,659 35 $63,385 -3 -$6,274

0 0 0 0 0 0 0 0

0 50 0 50 0 50 0 0

0 0 0 0 0 0 0 0

0 0 0 0 0 0 0 0

27 $67,462 38 $69,709 35 $63,435 -3 -$6,274

339 $56,551 357 $58,523 355 $58,230 -2 -$293

0 0 0 0 0 0 0 0

0 0 0 0 0 0 0 0

0 0 0 0 0 0 0 0

0 0 0 0 0 0 0 0

67 43,367 89 53,647 76 45,885 -13 -7,762

406 $99,918 446 $112,170 431 $104,115 -15 -$8,055

2,686 $1,465,201 2,957 $1,615,187 2,728 $1,442,207 -229 -$172,980

FTTPs FTTPs FTTPs FTTPs

218 $10,234 225 $10,657 224 $10,604 -1 -$53

287 28,052 490 29,004 488 28,859 -2 -145

505 $38,286 715 $39,661 712 $39,463 -3 -$198

0 $85,112 133 $82,550 132 $81,724 -1 -$825

(0) (643) (0) (643) (0) (643) (0) (0)

278 194,848 296 210,745 296 191,389 0 -19,356

259 88,239 267 94,823 267 90,081 0 -4,741

(0) (216) (0) (216) (0) (216) (0) (0)

0 0 0 0

0 0 0 0

537 $1,871,685 563 $2,042,966 563 $1,844,865 0 -$198,101

1

2 Of which $57.5 million in FY 2019, $70.0 million in FY 2020, and $50.0 million in FY 2021 is derived by transfer from the NIH Innovation Account under the 21st Century Cures Act.

3

Includes 21st Century Cures Act funding not obligated in FY 2019, and carried over into FY 2020.

NATIONAL INSTITUTES OF HEALTH

National Institute of Mental Health

Budget Mechanism - Total1,2

(Dollars in Thousands)

MECHANISM FY 2019 Final3 FY 2020 Enacted FY 2021 President's 

Budget

FY 2021

+/-

FY 2020 Enacted

Research Projects:

Noncompeting

Administrative Supplements 

Competing:

Renewal

New

Supplements

Subtotal, Competing

Subtotal, RPGs

SBIR/STTR

Research Project Grants

Research Centers:

Specialized/Comprehensive

Clinical Research

Biotechnology

Comparative Medicine

Research Centers in Minority Institutions

Research Centers

Other Research:

Research Careers

Cancer Education

Cooperative Clinical Research

Biomedical Research Support

Minority Biomedical Research Support

Other

Other Research

Total Research Grants

Ruth L Kirchstein Training Awards:

Individual Awards

Institutional Awards

Total Research Training

Research & Develop. Contracts

(SBIR/STTR) (non-add)

Intramural Research

All items in italics and brackets are non-add entries.

Res. Management & Support

Res. Management & Support (SBIR Admin) (non-add)

Construction 

Buildings and Facilities

Total, NIMH
NIMH-6

Major Changes in the Fiscal Year 2021 President’s Budget Request

Major changes by budget mechanism and/or budget activity detail are briefly described below. 

Note that there may be overlap between budget mechanism and activity details and these 

highlights will not sum to the total change for the FY 2021 President’s Budget request for 

NIMH. The FY 2021 President’s Budget request is $1,844.9 million, a decrease of $198.1 

million compared to the FY 2020 Enacted level.

Research Project Grants (-$158.7 million; total $1,274.7 million)

Funding for non-competing Research Project Grants increases by $16.9 million due to the need 

to fund projects receiving competing awards in prior years. Non-competing awards are funded at 

7.0 percent below full FY 2021 commitment levels in order to free up funds for competing 

grants. Competing Research Project Grants decrease by 237 grants or $166.0 million. This 

reduction is distributed across all programmatic areas and basic, translational or clinical research.

Research Centers (-$6.3 million; total $63.4 million)

This budget activity decreases by $6.3 million and will continue to fund research studies 

conducted by extramural universities and institutions.

Intramural Research Programs (-$19.4 million; total $191.4 million)

This budget activity decreases by $19.4 million and will continue to fund innovative research 

studies conducted by the Institute’s intramural scientists.

Research Management and Support (-$4.7 million; total $90.1 million)

This budget activity decreases by $4.7 million and will continue to support the oversight and 

management of scientific programs critical to fulfilling the Institute’s mission.
NIMH-7

FY 2020 Enacted

FY 2021 President's Budget

Net change

FTEs Budget Authority FTEs Budget Authority

$75,463 $485

75,463 1,118

75,463 -281

75,463 0

9,760 -1,755

106,167 1,144

$711

$46,051 $295

46,051 700

46,051 -172

46,051 0

4,787 -604

39,244 411

$629

$1,340

No. Amount No. Amount

1,683 $935,918 40 $15,421

484 282,451 -237 -166,002

95 56,288 -14 -8,070

2,262 $1,274,656 -211 -$158,652

35 $63,435 -3 -$6,274

431 104,115 -15 -8,055

712 39,463 -3 -198

132 81,724 -1 -825

$1,563,394 -$174,004

FTEs FTEs

296 $191,389 0 -$20,067

267 90,081 0 -5,370

0 0

0 0

563 $1,844,865 0 -$199,441

-$198,101

NATIONAL INSTITUTES OF HEALTH

National Institute of Mental Health

Summary of Changes

(Dollars in Thousands)

$2,042,966

$1,844,865

-$198,101

FY 2021 President's Budget Change from FY 2020 Enacted

CHANGES

A. Built-in:

1. Intramural Research:

a. Annualization of January 2020 pay increase & benefits

b. January FY 2021 pay increase & benefits

c. Paid days adjustment

d. Differences attributable to change in FTE

e. Payment for centrally furnished services

f. Cost of laboratory supplies, materials, other expenses, and non-recurring costs

Subtotal

2. Research Management and Support:

a. Annualization of January 2020 pay increase & benefits

b. January FY 2021 pay increase & benefits

c. Paid days adjustment

d. Differences attributable to change in FTE

e. Payment for centrally furnished services

f. Cost of laboratory supplies, materials, other expenses, and non-recurring costs

Subtotal

Subtotal, Built-in

FY 2021 President's Budget Change from FY 2020 Enacted

CHANGES

B. Program:

1. Research Project Grants:

a. Noncompeting

b. Competing

c. SBIR/STTR

Subtotal, RPGs

2. Research Centers

3. Other Research

4. Research Training

5. Research and development contracts

Subtotal, Extramural

6. Intramural Research

Subtotal, Program

Total changes

7. Research Management and Support

8. Construction

9. Buildings and Facilities
NIMH-8

Fiscal Year 2021 Budget Graphs

History of Budget Authority and FTEs:

Distribution by Mechanism:

Change by Selected Mechanism:
NIMH-9

FTE Amount FTE Amount FTE Amount FTE Amount

$763,649 $840,018 $756,314 -$83,705

142,982 157,660 141,609 -16,051

456,566 503,434 452,180 -51,254

168,549 173,598 156,986 -16,612

56,852 62,688 56,306 -6,382

$1,588,598 $1,737,398 $1,563,394 -$174,004

278 $194,848 296 $210,745 296 $191,389 0 -$19,356

259 $88,239 267 $94,823 267 $90,081 0 -$4,741

537 $1,871,685 563 $2,042,966 563 $1,844,865 0 -$198,101

1

Office of the Director

Subtotal, Extramural

Intramural Research

Research Management & Support

TOTAL

Includes FTEs whose payroll obligations are supported by the NIH Common Fund.

Extramural Research

Detail

Neuroscience & Basic Behavioral Science

Services & Intervention Research

Translational Research

AIDS Research

NATIONAL INSTITUTES OF HEALTH

National Institute of Mental Health

Budget Authority by Activity1

(Dollars in Thousands)

FY 2019 Final FY 2020 Enacted FY 2021 President's 

Budget

FY 2021

+/-

FY2020
NIMH-10 PHS Act/

Other Citation

U.S. Code

Citation

FY 2020 Enacted FY 2021 President's Budget

Section 301

Section 401(a) 42§281 Indefinite

Total, Budget Authority $2,042,966,000 $1,844,865,000

NATIONAL INSTITUTES OF HEALTH

National Institute of Mental Health

Authorizing Legislation

2020 Amount

Authorized

2021 Amount

Authorized

Research and Investigation 42§241 Indefinite Indefinite

National Institute of Mental Health

$2,042,966,000 $1,844,865,000

Indefinite
NIMH-11

Budget Estimate to 

Congress House Allowance Senate Allowance Appropriation

$1,517,006,000 $1,517,006,000 $1,460,671,000 $1,483,068,000

$2,802,999

$1,479,204,000 $1,483,687,000 $1,480,265,001

$2,960,530

($74,299,124)

$1,465,782,000 $1,456,041,000 $1,446,172,000

$0

$1,440,076,000 $1,463,036,000

$0

$1,489,417,000 $1,512,401,000 $1,520,260,000 $1,548,390,000

$0

$1,518,673,000 $1,599,747,000 $1,619,537,000 $1,601,931,000

$0

$1,244,901,000 $1,668,461,000 $1,724,568,000 $1,754,775,000

$0

$1,612,192,000 $1,790,231,000 $1,871,250,000 $1,870,296,000

$0

$1,630,422,000 $1,961,704,000 $2,076,244,000 $2,038,374,000

$0

$1,844,865,000

1

2 Includes funds derived by transfer from the NIH Innovation Account under the 21st Century Cures Act.

NATIONAL INSTITUTES OF HEALTH

National Institute of Mental Health

Appropriations History

Fiscal Year

2012

Rescission

2013

Rescission

Sequestration

2014

Rescission

2015

Rescission

Rescission

2016

Rescission

20171

Rescission

2018 2

Rescission

2021 2

Budget Estimate to Congress includes mandatory financing.

2019 2

Rescission

2020 2
NIMH-12

Justification of Budget Request

National Institute of Mental Health

Authorizing Legislation: Section 301 and title IV of the Public Health Service Act, as amended.

Budget Authority (BA):

FY 2019

Actual

FY 2020

Enacted

FY 2021

President’s

Budget

FY 2021 +/-

FY 2020

BA $1,871,684,999 $2,042,966,000 $1,844,865,000 -$198,101,000

FTE 537 563 563 0

Program funds are allocated as follows: Competitive Grants/Cooperative Agreements; 

Contracts; Direct Federal/Intramural and Other.

Director’s Overview

The National Institute of Mental Health (NIMH) is the lead federal agency for research on 

mental illnesses, with a mission to transform the understanding and treatment of mental illnesses 

through basic and clinical research, paving the way for prevention, recovery, and cure. 

In the United States, an estimated 47.6 million adults suffer from a mental illness, which may be 

significantly impairing and life-threatening.1 Mental disorders are the fourth leading cause of 

disability in the United States, accounting for 7.1 percent of all disability-adjusted life years.2 

One of the most tragic outcomes of untreated mental illness is suicide. Suicide accounts for the 

loss of over 47,000 American lives each year; it is the second leading cause of death in youth and 

young adults aged 10-34, and the tenth leading cause of death overall.3

NIMH supports a diverse portfolio of basic, translational, and clinical research, with the potential 

to improve clinical care over the short, medium, and long-term. To optimize its scientific 

investments across the long arc of mental health research, NIMH is guided by its Strategic Plan 

for Research. NIMH is currently revising this Plan to build on the successes of previous plans, 

provide a framework for research to leverage new opportunities for scientific exploration, and 

address new challenges in mental health. The new NIMH Strategic Plan for Research, which 

will be released in 2020, will provide a broad roadmap for the Institute’s research priorities over 

the next five years. 

1 Substance Abuse and Mental Health Services Administration. (2019). Key substance use and mental health 

indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication 

No. PEP19‐5068, NSDUH Series H‐54). Retrieved from https://www.samhsa.gov/data/

2

Institute of Health Metrics and Evaluation. http://ghdx.healthdata.org/gbd-results-tool accessed September 2019. 

http://ghdx.healthdata.org/gbd-results-tool?params=gbd-api-2017-permalink/abae84a95a64bd733ce16cdc380e82cd

3 CDC, NCIPC. WISQARS: http://www.cdc.gov/injury/wisqars/index.html accessed September 2019. 
NIMH-13

Where Were We 20 Years Ago? 

NIMH helped usher in the 1990s “Decade of the Brain,” laying the initial groundwork for 

NIMH-supported biological and genetic research on mental illnesses.4 By 2000, neuroscience 

research had yielded significant advances in developmental neurobiology; molecular genetics; 

and in understanding the neurotransmitters, receptors, and cytokines in brain disorders.5 The 

remarkable strides made during this era provided the foundation for the accelerated discovery in 

neuroscience seen today via novel programs such as the NIH Brain Research through Innovative 

Neurotechnologies® (BRAIN) Initiative. 

Twenty years ago, NIMH supported the Clinical Antipsychotic Trials of Intervention 

Effectiveness (CATIE) Study, a nationwide public health-focused clinical trial that compared the 

effectiveness of older (available since the 1950s) ‘typical’ and newer (available since 1990) 

‘atypical’ antipsychotic medications used to treat schizophrenia.6 CATIE was the largest, 

longest, and most comprehensive independent trial ever to examine existing therapies for 

schizophrenia. The aim of the CATIE study was to determine which medications provide the 

best treatment for schizophrenia. Clozapine, an atypical antipsychotic drug, was confirmed as 

the most effective drug for individuals with a poor symptom response to other antipsychotic 

medications, although clozapine was also associated with adverse side effects. To this day, 

clozapine remains the only antipsychotic that is indicated for treatment-resistant schizophrenia.

In the early 2000s, NIMH also supported the Sequenced Treatment Alternatives to Relieve 

Depression (STAR*D) Study to examine the effectiveness of different treatments for people with 

major depression who had not responded to initial treatment with an antidepressant.7 This was 

the largest and longest study ever conducted to evaluate depression treatment. STAR*D 

provided up to four treatment steps per patient and was designed to give guidance in selecting the 

best next-step treatment for the many patients who fail to get sufficient relief from their initial 

antidepressant. STAR*D investigators found no significant group differences between any of 11 

drug combination treatments. An overall analysis of the STAR*D results indicates that patients 

with difficult-to-treat depression can get well after trying several treatment strategies, but the 

odds of beating the depression diminish with every additional treatment strategy needed.8,9 The 

results of STAR*D also underscored the need for more effective treatment strategies and more 

patient-tailored interventions for the treatment of major depression.

Based in part on decades of NIMH-supported research, strong evidence has amassed for 

psychotherapies, such as cognitive behavioral therapy (CBT) and applied behavioral analysis 

(ABA). As an example, CBT was designed for depression and anxiety as a short-term therapy 

that focuses on changing thought processes that produce negative feelings. Cognitive therapy 

has proven as effective as medication in alleviating depression and even more effective in 

4 https://www.loc.gov/loc/brain/

5 https://pdfs.semanticscholar.org/e314/bf4dbd43731b67647c321c053d2735c6ae92.pdf

6 https://www.nimh.nih.gov/funding/clinical-research/practical/catie/index.shtml

7 https://www.nimh.nih.gov/funding/clinical-research/practical/stard/index.shtml

8 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314062/

9 https://ps.psychiatryonline.org/doi/full/10.1176/ps.2009.60.11.1439
NIMH-14

reducing relapse and recurrence.10 In fact, NIMH-funded research not only demonstrated the 

effectiveness of CBT but established a new standard for the field of psychotherapy. As another 

example, ABA is an intervention for autism based on behaviorist theory that desired behaviors 

can be taught through a system of rewards and consequences. Research in the 1990s 

demonstrated the efficacy of ABA, and this intervention is now a mandated service covered in 

most states.11,12

Where Are We Today?

Advances in neuroscience over the past decade, in part through the NIH BRAIN Initiative, have 

provided tools to look deeply into the function of neural circuits, and directly test hypotheses 

about brain-behavior relationships using noninvasive brain stimulation technologies. 

Researchers have also developed incredible technologies to measure and modulate the activity of 

specific circuits, such as optogenetics, chemogenetics, viral tracing, and high-resolution optical 

imaging. Today, noninvasive neuromodulation devices allow scientists to change function 

within circuits for therapeutic benefit. For example, this approach led to the Food and Drug 

Administration (FDA) approval of transcranial magnetic stimulation (TMS) for the treatment of 

depression and obsessive-compulsive disorder.13 TMS, which was originally a tool to study 

brain function, was first tested as a therapeutic intervention in the NIMH intramural research 

program.14 

In FY 2019, the FDA approved two treatments that were based on research conducted by NIMH 

researchers. The first technology derived from the NIMH’s intramural research patent portfolio 

to receive FDA approval was esketamine nasal spray medication for treatment-resistant 

depression.15 While typical antidepressants may take weeks to work, ketamine dramatically 

reduces depressive symptoms within hours.16 The FDA approved brexanolone intravenous 

infusion, the first-ever drug specifically designed to treat postpartum depression,17which impacts 

1 in 9 women in the United States.18 Research conducted in the 1980s in the NIMH’s intramural 

research program contributed to the formulation of this new therapy.19

Given the troubling rise in the national suicide rate in the past decades, suicide prevention 

research is an urgent priority for NIMH. As such, NIMH is supporting suicide prevention efforts 

in healthcare settings. Nearly half of individuals who die by suicide had some type of medical 

10 http://www.laskerfoundation.org/awards/show/development-of-cognitive-therapy-theory-and-practice/

11 https://www.ncbi.nlm.nih.gov/pubmed/8427693

12 https://www.autismspeaks.org/health-insurance-coverage-autism

13 https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-transcranial-magnetic-stimulationtreatment-obsessive-compulsive-disorder

14 https://www.ncbi.nlm.nih.gov/pubmed/8547583

15 https://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatmentresistant-depression-available-only-certified

16 https://www.nimh.nih.gov/about/director/messages/2019/new-hope-for-treatment-resistant-depression-guessingright-on-ketamine.shtml

17 https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-post-partum-depression

18 https://www.cdc.gov/mmwr/volumes/66/wr/mm6606a1.htm?s_cid=mm6606a1_w

19 https://www.nimh.nih.gov/news/science-news/2019/bench-to-bedside-nimh-research-leading-to-brexanolonefirst-ever-drug-specifically-for-postpartum-depression.shtml
NIMH-15

visit in the 30 days prior to death, and around 80 percent did so in the year before death.20,21 

NIMH research has identified a growing number of evidence-based suicide prevention tools that 

can be implemented in the healthcare system. NIMH-funded research shows that screening all 

patients doubles the number of people that can be identified as needing help for suicide risk.22 

NIMH is also supporting studies testing the best ways to deliver evidence-based interventions, 

such as Safety Planning, in various settings and populations.23 Safety Planning is an approach 

that reduces access to lethal means, identifies coping strategies to decrease risk of suicidal 

behavior, and lists people and resources that could help in crisis. NIMH-funded researchers have 

shown that this combination of screening, brief intervention, and follow-up contact reduced 

suicide attempts in the next year by about 30 percent.24 To build on these findings, NIMH 

continues to support research aimed at identifying who is most at risk for suicide, understanding 

the causes of suicide risk, developing interventions, and testing the effectiveness of suicide 

prevention services in real-world settings. 

Since NIMH launched the Recovery After an Initial Schizophrenia Episode (RAISE) project 

over a decade ago, researchers have made tremendous progress on early intervention services for 

people in the United States experiencing first episode psychosis, with an emphasis on 

coordinated specialty care (CSC).25 The RAISE project demonstrated that early intervention 

improves clinical outcomes among youth with first episode psychosis, including members of 

racial and ethnic minority groups, and that CSC is a feasible and cost-effective approach to early 

intervention for these individuals.26,27,28,29 Through collaborations with other federal agencies, 

NIMH has transformed these findings into real-world change. CSC is now the standard of care 

for early psychosis, with over 280 CSC programs across the country. RAISE has helped 

approximately 17,000 young people confronting the tremendous challenge of a first episode of 

psychosis by ensuring they have access to the best possible evidence-based care.

What Are We Investing in for the Future?

Building on the findings of RAISE and in support of expanding CSC programs across the United 

States, NIMH established the Early Psychosis Intervention Network (EPINET).30 EPINET aims 

to create an early psychosis “learning healthcare system,” in which data that are routinely 

collected in CSC programs as part of clinical practice drive continuous improvement in patient 

care and scientific discovery. NIMH recently funded five regional scientific hubs and one 

national data coordinating center that will standardize, collect, and aggregate data across 

community clinics and use computational methods to study CSC fidelity, quality, and treatment 

20 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026491/

21 https://www.ncbi.nlm.nih.gov/pubmed/12042175

22 https://www.ncbi.nlm.nih.gov/pubmed/26654691

23 https://www.ncbi.nlm.nih.gov/pubmed/29998307

24 https://www.ncbi.nlm.nih.gov/pubmed/28456130

25 https://www.nimh.nih.gov/health/topics/schizophrenia/raise/index.shtml

26 https://www.ncbi.nlm.nih.gov/pubmed/26481174

27 https://www.ncbi.nlm.nih.gov/pubmed/25772764

28 https://www.ncbi.nlm.nih.gov/pubmed/30152275

29 https://www.ncbi.nlm.nih.gov/pubmed/26834024

30 https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-150.html
NIMH-16

effectiveness.31 By studying large, nationally representative data sets, EPINET may provide 

crucial insights into how best to tailor early psychosis care for individuals and provide 

information to guide improvements in diagnosis and intervention.

Circuit neuroscience holds great promise for impact on mental health in the future. As noted 

above, neuroscience has undergone a revolution over the past decade with the advent of myriad 

technologies aimed at measuring and modulating the activity of specific circuits. Circuit 

neuroscience may enable diagnostic and treatment strategies that normalize the circuit 

dysfunctions that underlie psychiatric disorders. To drive progress in circuit neuroscience, 

NIMH supports cutting-edge research that seeks to reveal how brain cells and complex neural 

circuits dynamically interact to influence mental functions. 

Even though autism spectrum disorder (ASD) can be diagnosed as early as two years of age, 

most children are not diagnosed until after their fourth birthday.32 Screening children in primary 

care settings could help identify those at high risk for ASD, enabling early intervention and 

better long-term outcomes. As such, NIMH is supporting efforts to identify ASD at the earliest 

age possible. For example, NIMH funds the ASD Prevention, Early Detection, Engagement, and 

Services Research (ASD PEDS) Network, which comprises five separate but coordinated studies 

to test strategies for universal screening and early treatment.33 NIMH-funded research has 

identified risk markers within the first 12 months of age.34 Yet, a critical gap exists in translating 

these methods into practical, efficient, and inexpensive screening tools that could be 

implemented in the general population and within pediatric primary care settings. NIMH is 

encouraging research to develop and validate new screening methods for ASD that can be used 

in infancy.35

The healthcare landscape in the United States is constantly changing. To keep pace with these 

changes and address gaps between research and practice, NIMH published a funding opportunity 

announcement, A Practice-Based Research Network to Transform Mental Health Care: Science, 

Service Delivery and Sustainability.36 The initiative aims to transform the development, 

delivery, and sustainability of evidenced-based mental health practices and services in the United 

States. Specifically, this innovative approach provides the infrastructure that can be leveraged to 

support comparative effectiveness trials; harmonize electronic health record data across multiple 

integrated systems for common analyses; enable scientists to study rare events (e.g., suicide, 

ASD, first episode psychosis) by using and advancing innovative methodologies (e.g., predictive 

analytics); and, develop, test, and deploy large-scale mental health information technology 

interventions, generating data that will fuel the transformation of mental health care.

Overall Budget Policy: The FY 2021 President’s Budget request is $1,844.9 million, a decrease

of $198.1 million or 9.7 percent compared to the FY 2020 Enacted level.

31 https://www.nimh.nih.gov/news/science-news/2019/nih-announces-funding-awards-for-national-early-psychosislearning-community.shtml

32 https://www.cdc.gov/ncbddd/autism/addm-community-report/documents/addm-community-report-2018-h.pdf

33 https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-14-100.html

34 https://www.ncbi.nlm.nih.gov/pubmed/28592562

35 https://grants.nih.gov/grants/guide/rfa-files/rfa-mh-19-120.html

36 https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-225.html
NIMH-17

Program Descriptions

Office of the Director

The NIMH Office of the Director (OD) leads the Institute in implementing the NIMH mission to 

transform the understanding and treatment of mental illnesses. The OD provides scientific 

leadership, sets programmatic priorities, coordinates cross-cutting programs, determines Institute 

policy, and provides overall administrative and operational coordination for the Institute. The 

OD houses nine offices: Office on AIDS; Office of Autism Research Coordination; Office of 

Clinical Research; Office of Genomics Research Coordination; Office for Disparities Research 

and Workforce Diversity; Office of Management; Office of Rural Mental Health Research; 

Office of Science Policy, Planning, and Communications; and, Office of Technology 

Development and Coordination. Each of the offices within the OD play an important role in 

supporting the Institute.

As an example of research funded by OD, NIMH is planning to launch an initiative supporting 

projects aimed at implementing and sustaining evidence-based mental health practices in lowresource settings to achieve equity in outcomes.37

 Limited capital and human resources can 

create barriers to care delivery. The initiative would encourage innovative approaches to 

remediate barriers to provision, receipt, and/or benefit from evidence-based practices. Studies 

may also generate new information about factors integral to achieving equity in mental health 

outcomes, with due consideration for the needs of individuals across the life span. The ultimate 

goal of the initiative is to improve mental health outcomes for underserved populations and 

reduce or eliminate health disparities.

Budget Policy: The FY 2021 President’s Budget request is $56.3 million, a decrease of $6.4

million or 10.2 percent compared to the FY 2020 Enacted level.

Neuroscience and Basic Behavioral Science

The Division of Neuroscience and Basic Behavioral Science (DNBBS) provides support for 

research in the areas of basic neuroscience, genetics, integrative neuroscience, research training, 

resource development, and drug discovery. In cooperation with other NIMH programs and the 

wider research community, this program ensures that relevant basic scientific knowledge is 

generated and used in pursuit of improved methods that, in the long term, could be used to 

diagnose, treat, and prevent mental illnesses.

DNBBS funds grants across a range of research topics to enhance understanding of the basic 

neurobiology underlying mental illnesses. In FY 2021, DNBBS plans to support research to 

develop and validate behavioral measures in humans that can provide a readout of the brain 

subsystems relevant to anhedonia, a key symptom of major depression as well as other mental 

illnesses. In addition, DNBBS will support tool-development projects to further elucidate signals 

from the human genome that point to susceptibility to mental illnesses.

37 https://www.nimh.nih.gov/funding/grant-writing-and-application-process/concept-clearances/2019/effectivenessof-implementing-sustainable-evidence-based-mental-health-practices-in-low-resource-settings-to-achieve-equity-inoutcomes-for-traditionally-underserved-populations.shtml
NIMH-18

Program Portrait: Using Genetic Fine Mapping to Identify Causal Genetic Contributors to Mental 

Illnesses 

Tremendous progress has been made in understanding the role of genetics in the development of mental 

illnesses. Genome-wide association studies (GWAS) have uncovered links between certain variations in 

the genetic code and features of psychiatric disorders, including schizophrenia, autism, and depression. 

These links are mostly statistical relationships between common variations in the building blocks of DNA 

(called nucleotides) and a trait of interest. An immediate barrier to translating genetic associations into 

causal disease mechanisms is the uncertain relationship between these statistically identified genetic 

variations and the molecular changes that can result from them. Fine-mapping procedures aim to 

overcome this barrier by leveraging information about gene expression patterns and their functional 

impacts to determine which genetic variations in a genomic region of interest are most likely to be 

causally related to a trait. 

NIMH encourages research to develop and apply resources and tools for the large-scale and systematic 

genetic fine-mapping of serious mental illnesses and related traits.38 Such traits include disease status, as 

well as molecular features in neural tissues and cell types. Proposed studies may generate new data or use 

existing population-scale human data from groups with diverse ancestries. The ultimate goal is to provide 

the research community with high-confidence information on causal genetic contributors to allow for 

deeper insights into disease mechanisms. 

Budget Policy: The FY 2021 President’s Budget request is $756.3 million, a decrease of $83.7

million or 10.0 percent compared to the FY 2020 Enacted level.

Translational Research

The Division of Translational Research (DTR) supports integrative, multidisciplinary research 

and training programs that translate findings from basic science to discover the causes, 

mechanisms, and trajectories of mental illnesses, and develop effective interventions for 

individuals across the lifespan. DTR supports research using various forms of scientific analysis, 

including computational psychiatry and machine learning to elucidate the characteristics of, and 

risk factors for, mental illnesses; the neurobehavioral mechanisms of psychopathology; the 

trajectories of risk and resilience based on the interactive influences of genetics, brain 

development, environment, and experience; and, the design and testing of innovative treatments 

and interventions. As such, DTR-supported research efforts may have intermediate-term impact 

and pave the way towards effective treatment and prevention for mental illnesses.

One area of high priority for DTR is to improve outcomes for individuals exposed to trauma. 

Such outcomes may include post-traumatic stress disorder (PTSD), depression, insomnia, pain, 

substance use disorders, and suicide. A major gap in knowledge has been the lack of means to 

predict who will experience adverse outcomes from trauma before these outcomes occur, which 

would enable effective prevention strategies. To address this gap, NIMH, the Department of 

Defense, private foundations, and industry are funding the Aurora study to support the 

development of effective treatments and preventions that could improve understanding of trauma 

38 https://www.nimh.nih.gov/funding/grant-writing-and-application-process/concept-clearances/2019/fine-mappinggenome-wide-associated-loci-to-identify-proximate-causal-mechanisms.shtml
NIMH-19

outcome predictors.39 This landmark study with 5,000 participants across the United States will 

inform the development of predictive and diagnostic biomarkers that are needed to treat and 

prevent adverse outcomes in civilian and military veterans. In addition, DTR is supporting 

research using advanced digital techniques, including natural language processing, machine 

learning, and predictive coding, that aim to predict mental health outcomes, such as risk for 

suicide.40,41 DTR also supports work harnessing the latest advances in artificial intelligence to 

advance mechanistic understanding of how circuits in the brain shape behavior.42

Program Portrait: Using Opportunities for Invasive Neural Recording and Brain Stimulation in 

Humans to Advance Our Understanding of the Neural Circuitry of Mental Illnesses 

Invasive neural recordings can be used to explore the neural circuitry underlying complex moods, 

emotions, and behaviors with high spatial and temporal precision. Additionally, stimulation of the brain 

using implanted electrodes allows researchers to directly test hypotheses to better understand the structure 

and dynamics of neural networks. Together, invasive neural recordings and brain stimulation provide 

opportunities for researchers to understand which neural circuits are involved in complex behaviors in 

humans, and how to alter dysfunctional circuits into functional states, informing both invasive and noninvasive brain stimulation therapies of the future. 

NIMH is encouraging researchers to use invasive neural recording and brain stimulation opportunities in 

humans to study the neural circuity underlying mental illnesses.43 These opportunities arise during the 

normal treatment course of a variety of clinical conditions, such as when patients undergo deep brain 

stimulation surgery for Parkinson’s disease, when patients are monitored for epilepsy using 

electrocorticography, or when patients receive chronic brain implants for non-mental health and mental 

health-related conditions. Many people receiving these procedures may also have mental health 

diagnoses. Researchers must also consider patient privacy and ethical considerations, in maximizing 

benefit while minimizing risk to patients. Careful study of fluctuating mood patterns in patients with and 

without a mental illness can provide unique insights into the neural circuits that drive human behavior. 

Budget Policy: The FY 2021 President’s Budget request is $452.2 million, a decrease of $51.3

million or 10.2 percent compared to the FY 2020 Enacted level.

Services and Intervention Research

The Division of Services and Intervention Research (DSIR) supports research and training 

programs that evaluate the effectiveness of psychosocial, pharmacological, somatic, 

rehabilitative, and combined interventions to prevent or treat mental illnesses. DSIR funds 

research to refine and evaluate treatment and preventive interventions for children, adolescents, 

and adults, focusing on acute and long-term symptom reduction, remission, and improved 

community functioning. DSIR also supports mental health services research, including 

39 https://projectreporter.nih.gov/project_info_description.cfm?aid=9756462

40 https://www.ncbi.nlm.nih.gov/pubmed/30389840

41 https://www.ncbi.nlm.nih.gov/pubmed/30710497

42 https://grants.nih.gov/grants/guide/pa-files/PAR-19-344.html

43 https://www.nimh.nih.gov/funding/grant-writing-and-application-process/concept-clearances/2019/utilizinginvasive-recording-and-stimulating-opportunities-in-humans-to-advance-neural-circuitry-understanding-of-mentalhealth-disorders.shtml
NIMH-20

interventions to improve the quality and outcomes of care; organization- and system-level 

interventions to enhance service delivery; and strategies for widespread dissemination and 

implementation of evidence-based treatments into routine care settings. DSIR funds studies that 

are designed to have near-term impact, targeted at improving care for patients currently suffering 

from mental illnesses.

DSIR initiatives encourage practice-based research with near-term potential for improving 

intervention effectiveness and service delivery, as illustrated by the ALACRITY Research 

Center program (Advanced Laboratories for Accelerating the Reach and Impact of Treatments 

for Youth and Adults with Mental Illness).44,45 These centers incorporate a variety of 

transdisciplinary collaborations and prioritize a deployment-focused approach to yield 

interventions and service strategies that are relevant and can be rapidly integrated into practice. 

Many of the centers capitalize digital health platforms and data science methods to learn about 

mental illness onset and progression in clinical populations, improve diagnosis, and deliver 

targeted interventions via smart communication technologies. The centers also account for the 

perspectives of a variety of stakeholders, including patients, families, providers, and more. The 

currently funded ALACRITY Centers span a variety of key populations and practice settings; 

cover a range of science, spanning intervention refinement and optimization through 

implementation and services research; and, incorporate a variety of transdisciplinary 

collaborations.

Program Portrait: Telehealth to Optimize Mental Health Care for Emergency Department Patients at 

Risk for Suicide

Emergency departments (EDs) are critical settings for suicide preventive efforts. In the United States, 

there are nearly half a million visits to EDs for self-harm, and many more visits that involve suicide 

ideation.46 Research finds that existing ED providers identify only half of all patients at risk for suicide, 

many of whom could benefit from evidence-based care practices.47 These care practices include: 

universal risk detection efforts that can double the number of individuals identified to be in need of 

suicide prevention treatment;48 brief interventions such as the Safety Planning Intervention; and, followup telephone contacts that have resulted in fewer repeat suicide attempts (30 to 50 percent reduction).49,50

 

There is a shortage of ED-based mental health providers. Some EDs have begun to address this shortage 

by using telehealth to bring more mental health specialists into these health care settings, but questions 

remain regarding how telehealth services for suicide prevention care affect ED work flows. In particular, 

it is not known how telehealth is currently used to address suicide risk among ED patients; and, most 

importantly, it is not known whether telehealth-provided ED suicide prevention services are related to 

patients’ immediate, as well as longer-term, suicide morbidity and mortality outcomes. NIMH is 

encouraging research to identify feasible approaches to telehealth-supplied suicide prevention practices. 

44 https://grants.nih.gov/grants/guide/pa-files/PAR-16-354.html

45 https://grants.nih.gov/grants/guide/pa-files/PAR-18-701.html

46 https://webappa.cdc.gov/sasweb/ncipc/nfirates.html

47 https://www.ncbi.nlm.nih.gov/pubmed/26654691

48 https://www.ncbi.nlm.nih.gov/pubmed/15802695

49 https://www.ncbi.nlm.nih.gov/pubmed/28456130

50 https://www.ncbi.nlm.nih.gov/pubmed/29998307
NIMH-21

Of particular interest is whether this approach improves patients’ outcomes related to suicide (including 

intentional and non-intentional injuries and mortality) and increases their use of health care services.51

Budget Policy: The FY 2021 President’s Budget request is $141.6 million, a decrease of $16.1

million or 10.2 percent compared to the FY 2020 Enacted level.

AIDS Research 

The Division of AIDS Research (DAR) supports research and research training that addresses 

the priority areas outlined in the NIH HIV/AIDS Research Priorities and Guidelines for 

Determining AIDS Funding.52 DAR-supported research includes behavioral and social science 

studies aimed at reducing HIV/AIDS incidence through the development, testing, and 

implementation of new and improved prevention strategies, improving health outcomes of those 

living with HIV through improved linkage to care, and adherence to effective treatments. DAR 

also supports research to understand, prevent, and treat the neurological dysfunction associated 

with HIV infection. DAR is participating in cure research by supporting studies to eradicate or 

silence the HIV virus from biological reservoirs in the central nervous system (CNS), where the 

virus may evade detection and treatment. HIV latency in the CNS is critically important to 

consider in studies of eradication and reactivation. Many drugs designed to eradicate the virus 

are unable to penetrate the CNS, because the CNS acts as a protective reservoir for HIV. This 

work may also inform methods to prevent or treat the neurological comorbidities of HIV, such as 

cognitive and behavioral impairments, with targeted research to understand HIV-induced 

neurological pathology, with emphasis on long-term antiretroviral therapy. 

DAR research also places special emphasis on World Health Organization-defined key 

populations, health disparities, and the impact of mental illnesses that may increase the risk for 

contracting HIV or negatively impact the health outcomes of those living with HIV. 

Additionally, DAR ensures effective integration of biomedical approaches and multidisciplinary 

expertise are considered in agency-wide planning efforts, to help achieve an AIDS-free 

generation. 

Budget Policy: The FY 2021 President’s Budget request is $157.0 million, a decrease of $16.6

million or 9.6 percent compared to the FY 2020 Enacted level.

Intramural Research Programs

 

The Division of Intramural Research Programs (IRP) is the internal research component of 

NIMH, complementing the Institute’s extramural grant funding program. IRP scientists 

investigate basic, translational, and clinical aspects of brain function and behavior, conducting 

state-of-the-art research using unique NIH resources. In addition, the IRP provides an excellent 

environment for training the next generation of clinical and basic research scientists.

51 https://www.nimh.nih.gov/funding/grant-writing-and-application-process/concept-clearances/2019/mental-healthconsultation-via-telehealth-to-optimize-care-for-emergency-department-patients-with-suicide-risk.shtml

52 https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html
NIMH-22

IRP researchers are currently investigating innovative behavioral treatments and medications for 

children with severe mood dysregulation or anxiety and are using computational and multimodal 

neuroimaging approaches to understand adolescent depression. Recently, intramural researchers 

used functional magnetic resonance imaging (fMRI) to identify differences in how the brains of 

irritable youth react to frustration. In another fMRI study, researchers revealed differences in

brain activity in children with anhedonia. People who experience anhedonia have lost interest 

and pleasure in activities they used to enjoy.53 IRP scientists continue to explore novel 

medications for treatment-resistant depression in adults, including ketamine and other 

experimental fast-acting antidepressant medications, and are working to understand the 

neurobiological underpinnings of suicide. NIMH scientists also continue to investigate postinfectious neuroimmune disorders, including Pediatric Acute-onset Neuropsychiatric Syndrome 

(PANS) and PAN Disorder Associated with Streptococcal infection (PANDAS). These 

syndromes are characterized by a sudden onset of obsessive-compulsive disorder and/or severe 

eating restrictions, and associated characteristic cognitive, behavioral ,or neurological 

symptoms.54 Recent work in this area includes investigations into treatment options, as well as a 

nationwide effort to obtain prospective, longitudinal clinical information and samples and 

genetic material from children with PANS and their families.55

Budget Policy: The FY 2021 President’s Budget request is $191.4 million, a decrease of $19.4

million or 9.2 percent compared to the FY 2020 Enacted level.

Research Management and Support (RMS)

Research Management and Support (RMS) activities provide administrative, budgetary, 

logistical, and scientific support in the review, award, and monitoring of research and training 

grants, and research and development contracts. RMS functions include strategic planning, 

coordination, and evaluation of NIMH programs, regulatory compliance, coordination of global 

mental health efforts, and liaison with other Federal agencies, Congress, and the public. Through 

RMS activities, NIMH continues to provide accountability and administrative support for 

meritorious basic, clinical, and translational research and continues to promote health 

information dissemination, education, and outreach activities.

Budget Policy: The FY 2021 President’s Budget request is $90.1 million a decrease of $4.7

million or 5.0 percent compared to the FY 2020 Enacted level.

53 https://www.nimh.nih.gov/news/science-news/2019/nih-study-reveals-differences-in-brain-activity-in-childrenwith-anhedonia.shtml

54 https://www.nimh.nih.gov/health/publications/pandas/index.shtml

55 https://projectreporter.nih.gov/project_info_description.cfm?aid=9790789&icde=46818069
NIMH-23

FY 2020 Enacted FY 2021 President's 

Budget

FY 2021

+/-

FY 2020

Full-time equivalent 563 563 0

Full-time equivalent of overtime and holiday hours 0 0 0

Average ES salary $197 $201 $4

Average GM/GS grade 13.0 13.0 0.0

Average GM/GS salary $125 $127 $2

Average salary, grade established by act of July 1, 

1944 (42 U.S.C. 207) $0 $0 $0

Average salary of ungraded positions $140 $140 $1

FY 2020 Enacted FY 2021 President's 

Budget

FY 2021

+/-

FY 2020

Personnel Compensation

Full-Time Permanent 50,532 51,111 580

Other Than Full-Time Permanent 26,501 26,805 304

Other Personnel Compensation 2,544 2,574 29

Military Personnel 0 0 0

Special Personnel Services Payments 11,453 11,757 303

Subtotal Personnel Compensation $91,031 $92,246 $1,216

Civilian Personnel Benefits 28,177 29,267 1,090

Military Personnel Benefits 0 0 0

Benefits to Former Personnel 0 0 0

Subtotal Pay Costs $119,208 $121,513 $2,305

Travel & Transportation of Persons 3,546 3,052 -494

Transportation of Things 109 93 -16

Rental Payments to GSA 0 0 0

Rental Payments to Others 0 0 0

Communications, Utilities & Misc. Charges 1,028 885 -143

Printing & Reproduction 16 13 -2

Consulting Services 2,581 2,255 -326

Other Services 35,406 30,378 -5,028

Purchase of goods and services from government 

accounts

176,418 161,816 -14,602

Operation & Maintenance of Facilities 1,611 1,368 -243

R&D Contracts 20,501 16,982 -3,519

Medical Care 80 68 -12

Operation & Maintenance of Equipment 12,723 12,116 -607

Subsistence & Support of Persons 18 16 -3

Subtotal Other Contractual Services $249,339 $225,000 -$24,339

Supplies & Materials 6,950 5,894 -1,056

Equipment 7,921 6,743 -1,178

Land and Structures 0 0 0

Investments & Loans 0 0 0

Grants, Subsidies & Contributions 1,654,849 1,481,670 -173,179

Insurance Claims & Indemnities 0 0 0

Interest & Dividends 1 1 0

Refunds 0 0 0

Subtotal Non-Pay Costs $1,923,758 $1,723,352 -$200,406

Total Budget Authority by Object Class $2,042,966 $1,844,865 -$198,101

1

NATIONAL INSTITUTES OF HEALTH

National Institute of Mental Health

Budget Authority by Object Class1

(Dollars in Thousands)

Total compensable workyears:

OBJECT CLASSES

11.1

11.3

11.5

11.7

11.8

11.9

12.1

12.2

13.0

21.0

22.0

23.1

23.2

23.3

24.0

25.1

25.2

25.3

25.4

25.5

25.6

25.7

25.8

25.0

26.0

31.0

32.0

33.0

41.0

42.0

43.0

44.0

Includes FTEs whose payroll obligations are supported by the NIH Common Fund.
NIMH-24

OBJECT CLASSES FY 2020 Enacted FY 2021 President's 

Budget

FY 2021

+/-

FY 2020

Personnel Compensation

Full-Time Permanent (11.1) $50,532 $51,111 $580

Other Than Full-Time Permanent (11.3) 26,501 26,805 304

Other Personnel Compensation (11.5) 2,544 2,574 29

Military Personnel (11.7) 0 0 0

Special Personnel Services Payments (11.8) 11,453 11,757 303

Subtotal Personnel Compensation (11.9) $91,031 $92,246 $1,216

Civilian Personnel Benefits (12.1) $28,177 $29,267 $1,090

Military Personnel Benefits (12.2) 0 0 0

Benefits to Former Personnel (13.0) 0 0 0

Subtotal Pay Costs $119,208 $121,513 $2,305

Travel & Transportation of Persons (21.0) $3,546 $3,052 -$494

Transportation of Things (22.0) 109 93 -16

Rental Payments to Others (23.2) 0 0 0

Communications, Utilities & Misc. Charges (23.3) 1,028 885 -143

Printing & Reproduction (24.0) 16 13 -2

Other Contractual Services:

Consultant Services (25.1) 2,581 2,255 -326

Other Services (25.2) 35,406 30,378 -5,028

Purchases from government accounts (25.3) 106,374 92,111 -14,263

Operation & Maintenance of Facilities (25.4) 1,611 1,368 -243

Operation & Maintenance of Equipment (25.7) 12,723 12,116 -607

Subsistence & Support of Persons (25.8) 18 16 -3

Subtotal Other Contractual Services $158,714 $138,244 -$20,469

Supplies & Materials (26.0) $6,950 $5,894 -$1,056

Subtotal Non-Pay Costs $170,362 $148,182 -$22,180

Total Administrative Costs $289,570 $269,696 -$19,874

NATIONAL INSTITUTES OF HEALTH

National Institute of Mental Health

Salaries and Expenses

(Dollars in Thousands)
NIMH-25

Civilian Military Total Civilian Military Total Civilian Military Total

Division of AIDS Research

Direct: 16 - 16 16 - 16 16 - 16

Reimbursable: - - - - - - - - -

Total: 16 - 16 16 - 16 16 - 16

Division of Extramural Activities

Direct: 43 - 43 43 - 43 43 - 43

Reimbursable: - - - - - - - - -

Total: 43 - 43 43 - 43 43 - 43

Division of Intramural Research Programs

Direct: 271 - 271 289 - 289 289 - 289

Reimbursable: 7 - 7 7 - 7 7 - 7

Total: 278 - 278 296 - 296 296 - 296

Division of Neuroscience and Basic Behavioral Science

Direct: 25 - 25 25 - 25 25 - 25

Reimbursable: - - - - - - - - -

Total: 25 - 25 25 - 25 25 - 25

Division of Services and Intervention Research

Direct: 15 - 15 15 - 15 15 - 15

Reimbursable: - - - - - - - - -

Total: 15 - 15 15 - 15 15 - 15

Division of Translational Research

Direct: 27 - 27 27 - 27 27 - 27

Reimbursable: - - - - - - - - -

Total: 27 - 27 27 - 27 27 - 27

Office of the Director

Direct: 127 - 127 136 - 136 136 - 136

Reimbursable: 6 - 6 5 - 5 5 - 5

Total: 133 - 133 141 - 141 141 - 141

Total 537 - 537 563 - 563 563 - 563

FTEs supported by funds from Cooperative Research and 

Development Agreements. 0 0 0 0 0 0 0 0 0

FISCAL YEAR

2017

2018

2019

2020

2021

NATIONAL INSTITUTES OF HEALTH

National Institute of Mental Health

Detail of Full-Time Equivalent Employment (FTE)

OFFICE/DIVISION

FY 2019 Final FY 2020 Enacted FY 2021 President's Budget

Includes FTEs whose payroll obligations are supported by the NIH Common Fund.

13.0

Average GS Grade

12.6

12.7

12.8

13.0
NIMH-26

FY 2019 Final FY 2020 Enacted FY 2021 President's 

Budget

1 1 1

188,243 197,272 201,271

70 70 70

77 77 77

109 135 135

77 77 77

33 33 33

0 0 0

13 13 13

5 5 5

7 7 7

0 0 0

0 0 0

1 1 1

1 1 1

0 0 0

0 0 0

393 419 419

0 0 0

0 0 0

0 0 0

0 0 0

0 0 0

0 0 0

0 0 0

174 174 174

397 397 397

568 594 594

537 563 563

188,243 197,272 201,271

12.8 13.0 13.0

119,161 125,333 127,393

1

NATIONAL INSTITUTES OF HEALTH

National Institute of Mental Health

Detail of Positions1

GRADE

Total, ES Positions

Total, ES Salary

GM/GS-15

GM/GS-14

GM/GS-13

GS-12

GS-11

GS-10

GS-9

GS-8

GS-7

GS-6

GS-5

GS-4

GS-3

GS-2

GS-1

Subtotal

Grades established by Act of July 1, 1944 (42 U.S.C. 207)

Assistant Surgeon General

Director Grade

Senior Grade

Full Grade

Senior Assistant Grade

Assistant Grade

Subtotal

Ungraded

Average ES salary

Average GM/GS grade

Average GM/GS salary

Includes FTEs whose payroll obligations are supported by the NIH Common Fund.

Total permanent positions

Total positions, end of year

Total full-time equivalent (FTE) employment, end of year